Sperling Prostate Center

Tag: multiparametric MRI

The “Good New Days” of Prostate Cancer

prostate cancer and walking
Growing up, I sometimes heard older family members talk about “the Good Old Days.” Compared to their memories of “simpler times,” they now felt challenged by the fast pace of increasing technological complexities. In fact, the arc of technological advances over the centuries is breathtaking! According to a Feb. 27, 2023 World Economic Forum piece, keep reading

Artificial Intelligence in Medicine: Reducing False Positives on MRI

No one is perfect, including radiologists who read and interpret multiparametric MRI (mpMRI) prostate scans. However, some are better than others. Studies show that experienced readers are generally more accurate than less experienced readers. In fact, based on the number of MRIs reviewed over time as well as continuing education (conferences, training workshops, classes, etc.), keep reading

Can mpMRI Predict Prostate Cancer Stage?

MRI/Ultrasound Fusion May Come with a Pitfall Called Registration Error
If you are diagnosed with prostate cancer, you want to know, with as much accuracy as possible PSA and its variants - determined by blood test, Gleason score/Gleason Grade Group - determined by biopsy, and clinical stage - determined the old-fashioned way by combination of digital rectal exam or DRE, biopsy, inadequate information from ultrasound, and educated guess... keep reading

Overused Random Biopsies: The Real Culprit

Numerous studies have validated the hypothesis that if mpMRI does not detect significant prostate cancer (PCa), no biopsy is needed; but if a biopsy is indicated, MRI-targeted biopsy overcomes the problems of the TRUS random biopsies. It minimizes the number of needles while maximizing diagnostic accuracy. As one paper states... keep reading
WordPress Image Lightbox